Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 8/20 | 1.00 |
| ▸ | SHBG | P04278 | 7/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 1.00 |
| ▸ | TSHR | P16473 | 5/20 | 1.00 |
| ▸ | NR3C1 | P04150 | 4/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 4/20 | 1.00 |
| ▸ | PGR | P06401 | 3/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | ESR1 | P03372 | 2/20 | 1.00 |
| ▸ | THRB | P10828 | 1/20 | 1.00 |
| ▸ | AR | P10275 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.72 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.72 |
| ▸ | HTR2B | P41595 | 1/20 | 0.72 |
| ▸ | BLM | P54132 | 5/20 | 0.67 |
| ▸ | SERPINA6 | P08185 | 4/20 | 0.67 |
| ▸ | MAPT | P10636 | 3/20 | 0.67 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethisterone SCHEMBL7604035 | 1.00 | LMNA (1.00) | LMNASHBGSMN1; SMN2TSHRNR3C1 | |
| Ethisterone SCHEMBL606819 | 1.00 | LMNA (1.00) | LMNASHBGSMN1; SMN2TSHRNR3C1 | |
| Ethisterone SCHEMBL15581276 | 1.00 | LMNA (1.00) | LMNASHBGSMN1; SMN2TSHRNR3C1 | |
| Ethisterone SCHEMBL14433089 | 1.00 | LMNA (1.00) | LMNASHBGSMN1; SMN2TSHRNR3C1 | |
| Ethisterone SCHEMBL12417537 | 1.00 | LMNA (1.00) | LMNASHBGSMN1; SMN2TSHRNR3C1 | |
| Ethisterone SCHEMBL16864523 | 1.00 | LMNA (1.00) | LMNASHBGSMN1; SMN2TSHRNR3C1 | |
| Ethisterone SCHEMBL16691330 | 1.00 | LMNA (1.00) | LMNASHBGSMN1; SMN2TSHRNR3C1 | |
| Ethisterone SCHEMBL780055 | 1.00 | LMNA (1.00) | LMNASHBGSMN1; SMN2TSHRNR3C1 | |
| Ethisterone SCHEMBL28541256 | 0.99 | LMNA (0.98) | LMNASHBGSMN1; SMN2TSHRNR3C1 | |
| Ethisterone SCHEMBL11152514 | 0.96 | LMNA (0.92) | LMNASHBGSMN1; SMN2TSHRNR3C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4342 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250195450-A1 | BIOERODIBLE DRUG DELIVERY IMPLANTS | HERA HEALTH SOLUTIONS INC. | 2025-06-19 | — | — | US | claimed |
| US-12318395-B2 | Ethinyl estradiol-β-cyclodextrin complex and process for preparing thereof | LABORATORIOS LEON FARMA, S.A. (ES) | 2025-06-03 | — | — | US | claimed |
| EP-3884914-B1 | AN OVERMOULDABLE SUBSTRATE AND USES THEREOF | QPHARMA AB (SE) | 2025-05-21 | — | — | EP | claimed |
| US-20250152556-A1 | ETRASIMOD FOR USE IN TREATING S1P1 RECEPTOR-ASSOCIATED DISORDERS IN COMBINATION WITH HORMONE TREATMENT | ARENA PHARMACEUTICALS, INC. (US) | 2025-05-15 | — | — | US | claimed |
| WO-2025044131-A1 | METHODS FOR PRODUCING OPHTHALMIC COMPOSITION OF POORLY WATER-SOLUBLE DRUGS | THERATOCULAR BIOTEK CO., LTD. (CN) | 2025-03-06 | — | — | WO | claimed |
| US-12178824-B2 | Orodispersible formulations | MILLICENT PHARMA LIMITED (IE) | 2024-12-31 | — | — | US | claimed |
| CN-119125584-A | Testosterone immunoassay reagent sample release agent formula | 深圳市辰纳生物科技有限公司 | 2024-12-13 | — | — | CN | claimed |
| CN-119097706-A | Natural product for preventing and treating vascular calcification and application thereof | 江南大学 | 2024-12-10 | — | — | CN | claimed |
| CN-118541151-A | Is Qu Mode for use in combination with hormonal therapy for the treatment of S1P1 receptor related disorders | 艾尼纳制药公司 | 2024-08-23 | — | — | CN | claimed |
| CN-117877666-A | XGBoost algorithm-based method for guiding gonadotrophin initial administration dosage selection | 云南大学 | 2024-04-12 | — | — | CN | claimed |
| US-4622244-A | SOLIDIFICATION | THE WASHINGTON UNIVERSITY (US) | 1986-11-11 | — | — | US | claimed |
| US-4540564-A | DIHYDROPYRIDINE AND/OR PYRIDINIUM SALT REDOX CARRIER | UNIVERSITY OF FLORIDA (US) | 1985-09-10 | — | — | US | claimed |
| EP-0110955-A1 | BRAIN-SPECIFIC DRUG DELIVERY. | UNIV FLORIDA (US) | 1984-06-20 | — | — | EP | claimed |
| WO-1983003968-A1 | BRAIN-SPECIFIC DRUG DELIVERY | UNIVERSITY OF FLORIDA (US) | 1983-11-24 | — | — | WO | claimed |
| US-4346709-A | Drug delivery devices comprising erodible polymer and erosion rate modifier | ALZA CORPORATION (US) | 1982-08-31 | — | — | US | claimed |
| EP-0050867-A1 | Vaginal ring | SCHERING AKTIENGESELLSCHAFT (DE) | 1982-05-05 | — | — | EP | claimed |
| US-4211701-A | Spironolactone process | THE UPJOHN COMPANY (US) | 1980-07-08 | — | — | US | claimed |
| US-4057542-A | Process for the preparation of 17β-hydroxy-3-oxo-17α-pregn-4-ene-21-carboxylic acid γ-lactone | G. D. SEARLE & CO. (US) | 1977-11-08 | — | — | US | claimed |
| US-4016270-A | Method for treating dysmenorrhea with a uterine therapeutic system | ALZA CORPORATION (US) | 1977-04-05 | — | — | US | claimed |
| US-4014988-A | Method for treating hypermenorrhea with uterine therapeutic system | ALZA CORPORATION (US) | 1977-03-29 | — | — | US | claimed |